SPINAL MUSCULAR ATROPHY TYPE 3
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE 3 trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal zaps tested to boost movement in Muscle-Weakening disease
Disease control CompletedThis small pilot study explored whether a temporary spinal cord stimulator could improve leg strength and motor control in people with types 3 or 4 spinal muscular atrophy (SMA). Three participants had thin wires implanted near their lower spine for up to 29 days to deliver mild …
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: NA • Sponsor: Marco Capogrosso • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Muscle-Boosting drug shows promise for children with rare neuromuscular disease
Disease control CompletedThis completed Phase 3 trial tested whether adding the experimental drug apitegromab to standard SMA treatments could improve muscle function in 188 children and young adults (ages 2-21) with later-onset spinal muscular atrophy. All participants were already receiving approved SM…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC